The SARS-CoV-2 Omicron (B.1.1.529) variant and effectiveness of existing vaccines: What we know so far
- PMID: 34989403
- PMCID: PMC9015560
- DOI: 10.1002/jmv.27574
The SARS-CoV-2 Omicron (B.1.1.529) variant and effectiveness of existing vaccines: What we know so far
Keywords: B.1.1.529; COVID-19; Covid-19 vaccines; Omicron; SARS-CoV-2; coronavirus.
Conflict of interest statement
The authors declare that there are no conflict of interests.
References
-
- Russell RS. Omicron: a speculation on its potential superpowers. Viral Immunol. 2021;34(10):664‐665. - PubMed
-
- Cele S, Jackson L, Khan K, et al. SARS‐CoV‐2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. medRxiv. Published online December 11, 2021. doi:10.1101/2021.12.08.21267417 - DOI
-
- Burki TK. Omicron variant and booster COVID‐19 vaccines. Lancet Respir Med. Published online December 17, 2021;(21): doi:10.1016/S2213-2600(21)00559-2 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
